Doximity (DOCS) Research & Development (2020 - 2026)

Doximity (DOCS) has 7 years of Research & Development data on file, last reported at $39.1 million in Q1 2026.

• On a quarterly basis, Research & Development rose 57.67% year-over-year to $39.1 million in Q1 2026; TTM through Mar 2026 was $149.2 million, a 60.4% increase from a year earlier, with the FY2026 full-year figure at $130.7 million, up 40.48% from the prior year.
• Research & Development for Q1 2026 stood at $39.1 million, up from $34.6 million in the prior quarter.
• Over the last five years, Research & Development for DOCS reached as high as $47.2 million in Q1 2022 and fell as low as -$10.2 million in Q1 2023.
• Historically, Research & Development has averaged $26.8 million across 5 years, with a median of $24.8 million in 2025.
• Across the five-year window, Research & Development surged 8323.52% in 2022 and tumbled 121.59% in 2023, its largest moves.
• Year by year, Research & Development stood at $33.2 million in 2022, then tumbled by 39.96% to $19.9 million in 2023, then climbed by 12.41% to $22.4 million in 2024, then soared by 54.3% to $34.6 million in 2025, then gained by 13.04% to $39.1 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $39.1 million in Q1 2026, $34.6 million in Q4 2025, and $39.2 million in Q3 2025.